| |
Company
Roster
|
|
Total
Insiders : |
29 |
|
|
|
Total
Direct Shares :
|
6,264,504 |
|
|
Total
Indirect Shares :
|
15,497,020 |
| |
%
Held by Insiders:
|
16.61% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Hannay Michael Charles Ferguson |
|
2024-04-11 |
22,891 |
|
0 |
| Keen Nicholas |
|
2024-04-03 |
62,803 |
2024-04-03 |
7,000 |
| Milnes Alistair |
|
2024-04-03 |
72,241 |
2022-01-03 |
0 |
| Skynner Michael |
|
2024-04-03 |
94,884 |
|
0 |
| Lee Kevin |
|
2024-04-03 |
387,270 |
|
0 |
| Crockett Nigel |
|
2024-04-03 |
47,761 |
2021-07-06 |
0 |
| Thompson Travis Alvin |
|
2024-04-03 |
23,223 |
|
0 |
| Sands Stephen H. |
|
2024-02-20 |
12,000 |
2024-02-20 |
0 |
| Arroyo Santiago |
|
2024-02-06 |
39,000 |
2024-01-02 |
0 |
| Legault Pierre |
Director |
2024-01-02 |
33,500 |
2021-03-12 |
0 |
| Jordan Veronica Gh |
Director |
2024-01-02 |
16,750 |
2022-01-03 |
0 |
| Young Alethia |
Chief Financial Officer |
2024-01-02 |
12,000 |
2024-01-02 |
0 |
| Winter Gregory Paul |
Director |
2024-01-02 |
180,677 |
|
0 |
| Kender Richard N |
Director |
2024-01-02 |
16,750 |
2022-01-03 |
0 |
| Bourque Janice |
Director |
2024-01-02 |
16,750 |
2022-01-03 |
0 |
| Guiterrez-Ramos Jose Carlos |
Director |
2024-01-02 |
16,750 |
2022-01-03 |
0 |
| Kalowski Lee |
President and CFO |
2023-04-03 |
30,309 |
2020-11-23 |
0 |
| Smethurst Dominic |
Chief Medical Officer |
2023-01-03 |
36,699 |
2021-09-23 |
0 |
| Cambridge Innovation Capital (jersey) Ltd |
10% Owner |
2019-05-29 |
1,751,437 |
2019-05-28 |
0 |
| Harland Deborah |
Director |
2019-05-28 |
0 |
2019-05-28 |
1,915,275 |
| Bingham Kate |
Director |
2019-05-28 |
0 |
2021-07-14 |
38,708 |
| Glaxosmithkline Plc |
10% Owner |
2019-05-28 |
0 |
2020-07-15 |
1,910,531 |
| Sv Life Sciences Fund V Strategic Partners, L.p. |
10% Owner |
2019-05-28 |
0 |
2019-05-28 |
39,637 |
| Vertex Global Healthcare Fund I Pte Ltd. |
10% Owner |
2019-05-28 |
1,621,168 |
2019-05-28 |
0 |
| Anstey Michael |
Director |
2019-05-28 |
0 |
2019-05-28 |
1,751,437 |
| Aquila Investments Iv |
10% Owner |
2019-05-28 |
0 |
2019-05-28 |
1,957,961 |
| Novartis Ag |
10% Owner |
2019-05-28 |
1,769,641 |
2019-05-28 |
0 |
| Ng Carolyn |
Director |
2019-05-28 |
0 |
2019-05-28 |
1,427,151 |
| Baker Julian |
|
|
0 |
2024-04-18 |
6,449,320 |
|
